A venture firm with offices in Germany and in Eastern Europe has over €850 million in total assets under management, and has raised a total of six funds; the most recent fund closed in 2016. The firm typically invests €1-5 million in venture-stage opportunities, or up to €15 million in growth-stage opportunities. The firm is currently focused on companies based in Europe.
Within the life science sector the firm is currently focused on medical technology, diagnostics, life science tools, and digital health across Europe. The firm is open to opportunities in any indication area and at any phase of development.
The firm is open to investing in companies at the early commercialization stage, and companies generating steady revenues.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com